Lataa...
Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre
INTRODUCTION: Pancreatic cancer (PC), even in the absence of metastatic disease, has a dismal prognosis. One-third of them are borderline resectable (BRPC) or locally advanced unresectable PC (LAUPC) at diagnosis. There are limited prospective data supporting the best approach on these tumours. Neoa...
Tallennettuna:
| Julkaisussa: | ESMO Open |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7684818/ https://ncbi.nlm.nih.gov/pubmed/33229503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000929 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|